Publications by authors named "Nora Vail"

Claim this Profile
D
Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation.
Cole R Scholtz, Luke C Doskey, Sai Giridhar Sarma Kandanur, Nora R Vail, Erika R Roderick

Eur J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease.
Luke C Doskey, Cole R Scholtz, Nora R Vail, Shalil Khanal, Amani L Lee

J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Methyl-1,2,3-Triazoles as -Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity.
Huarui Cui, Angela S Carlson, Mary A Schleiff, Anand Divakaran, Jorden A Johnson, Nora R Vail

J Med Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of transition-state analogs as inhibitors of the bacterial quorum sensing autoinducer synthase CepI.
Erin L Higgins, Julian S Kellner-Rogers, Alexandra M Estanislau, Alec C Esposito, Nora R Vail

Bioorg Med Chem Lett· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Affinity for 3-Amino-Chromane-Derived σ Receptor Ligands.
Matthew R Porter, Haiyan Xiao, Sanjay Maity, Nora Vail, Sylvia B Smith

ACS Omega· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis